DrugPatentWatch Database Preview

Viltolarsen - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for viltolarsen and what is the scope of patent protection?

Viltolarsen is the generic ingredient in one branded drug marketed by Nippon Shinyaku and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Viltolarsen has fifty-one patent family members in twenty countries.

Summary for viltolarsen

International Patents:	51
US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	1
Clinical Trials:	4
What excipients (inactive ingredients) are in viltolarsen?	viltolarsen excipients list
DailyMed Link:	viltolarsen at DailyMed

Recent Clinical Trials for viltolarsen

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
NS Pharma, Inc.	Phase 2
Nippon Shinyaku Co., Ltd.	Phase 2
NS Pharma, Inc.	Phase 4

See all viltolarsen clinical trials

US Patents and Regulatory Information for viltolarsen

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nippon Shinyaku	VILTEPSO	viltolarsen	SOLUTION;INTRAVENOUS	212154-001	Aug 12, 2020		RX	Yes	Yes			Y	Y
Nippon Shinyaku	VILTEPSO	viltolarsen	SOLUTION;INTRAVENOUS	212154-001	Aug 12, 2020		RX	Yes	Yes
Nippon Shinyaku	VILTEPSO	viltolarsen	SOLUTION;INTRAVENOUS	212154-001	Aug 12, 2020		RX	Yes	Yes			Y	Y

International Patents for viltolarsen

Country	Patent Number	Estimated Expiration
Japan	2021104037
Croatia	P20191770
Japan	6867619